We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-11.91%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$529M
AUM Growth
-$226M
Cap. Flow
-$154M
Cap. Flow %
-29.11%
Top 10 Hldgs %
40.03%
Holding
118
New
32
Increased
20
Reduced
26
Closed
35

Top Buys

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$10.4M
2
MTD icon
Mettler-Toledo International
MTD
+$7.97M
3
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$6.5M
4
ELAN icon
Elanco Animal Health
ELAN
+$5.18M
5
PACB icon
Pacific Biosciences
PACB
+$4.74M

Top Sells

Rank Stock Value
1
OM icon
Outset Medical
OM
+$6.37M
2
RCM
R1 RCM Inc. Common Stock
RCM
+$5.89M
3
GH icon
Guardant Health
GH
+$4.1M
4
INSP icon
Inspire Medical Systems
INSP
+$3.7M
5
QTRX icon
Quanterix
QTRX
+$3.49M

Sector Composition

Rank Sector Weight
1 Healthcare 35.57%
2 Consumer Staples 1.71%
3 Industrials 0.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GH icon
76
Guardant Health
GH
$22.2B
$680K 0.13%
22,943
-116,648
-84% -$4.1M
ORGO icon
77
CALL
Organogenesis Holdings
ORGO
$233M
$318K 0.06%
+100,000
New +$318K
NSPR icon
78
CALL
InspireMD
NSPR
$40.3M
$304K 0.06%
+93,100
New +$297K
TALKW
79
DELISTED
Talkspace Inc Warrant
TALKW
$43.5K 0.01%
378,000
– –
SLGCW
80
DELISTED
SomaLogic, Inc. Warrant
SLGCW
$38.3K 0.01%
173,876
– –
MDVL
81
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$18.8K ﹤0.01%
58,070
+56,909
+4,902% +$584K
MAPSW
82
DELISTED
WM TECHNOLOGY INC WTS
MAPSW
$7.41K ﹤0.01%
50,000
– –
RCKTW icon
83
Rocket Pharmaceuticals Warrant
RCKTW
$256K
$7.3K ﹤0.01%
42,960
– –
ADPT icon
84
CALL
Adaptive Biotechnologies
ADPT
$4.02B
– –
-177,700
Closed -$1.19M
ADPT icon
85
Adaptive Biotechnologies
ADPT
$4.02B
– –
-155,059
Closed -$1.04M
AKYA
86
DELISTED
Akoya BioSciences
AKYA
– –
-360,789
Closed -$2.67M
ALC icon
87
PUT
Alcon
ALC
$35.6B
– –
-48,400
Closed -$3.97M
AMN icon
88
AMN Healthcare
AMN
$1.26B
– –
-19,925
Closed -$2.17M
ATEC icon
89
Alphatec Holdings
ATEC
$1.49B
– –
-133,143
Closed -$2.39M
BAX icon
90
CALL
Baxter International
BAX
$13.9B
– –
-96,000
Closed -$4.37M
COO icon
91
Cooper Companies
COO
$15B
– –
-17,980
Closed -$1.72M
CRL icon
92
PUT
Charles River Laboratories
CRL
$13.6B
– –
-13,600
Closed -$2.86M
DHR icon
93
PUT
Danaher
DHR
$145B
– –
-76,140
Closed -$16.2M
EVH icon
94
Evolent Health
EVH
$471M
– –
-39,397
Closed -$1.19M
GDX icon
95
PUT
VanEck Gold Miners ETF
GDX
$27.8B
– –
-121,100
Closed -$9.54M
GHRS icon
96
GH Research
GHRS
$2.08B
– –
-25,000
Closed -$297K
IART icon
97
PUT
Integra LifeSciences
IART
$1.35B
– –
-52,700
Closed -$2.17M
ICUI icon
98
CALL
ICU Medical
ICUI
$4.48B
– –
-85,900
Closed -$15.3M
ICUI icon
99
ICU Medical
ICUI
$4.48B
– –
-13,881
Closed -$2.47M
ILMN icon
100
CALL
Illumina
ILMN
$29.1B
– –
-38,653
Closed -$7.05M
1 2 3
4
5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q3 2023 Portfolio in Review

As of Q3 2023, Pura Vida Investments held 118 positions worth $529M, down 30% from $755M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Pura Vida Investments withdrew a net $154M in Q3 2023, closing 35 positions and reducing 26 holdings. Its most notable exit was ViewRay, Inc., an estimated $3.09M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 30% a quarter earlier, followed by Consumer Staples and Industrials.

Against the trend, Pura Vida Investments opened a new position in Kenvue worth $9.06M.

  • Pura Vida Investments's largest Q3 2023 buy was Kenvue: 451,279 shares worth $9.06M.
  • Pura Vida Investments added most to Establishment Labs in Q3 2023, an estimated $3.18M increase.
  • Pura Vida Investments's biggest Q3 2023 reduction was Outset Medical, cutting an estimated $6.37M.
  • Pura Vida Investments fully exited ViewRay, Inc. in Q3 2023, selling an estimated $3.09M.
  • Pura Vida Investments's ten largest holdings make up 40% of its $529M portfolio in Q3 2023.
  • Pura Vida Investments opened 32 new positions and closed 35 in Q3 2023.
  • Pura Vida Investments's portfolio value fell 30% quarter-over-quarter to $529M.

Based on Pura Vida Investments's 13F filing for Q3 2023, filed 14 Nov 2023.